Vaccination with a MHC class II peptide attenuates cellular and humoral responses against tAChR and suppresses clinical EAMG.
about
Vaccination with a MHC class II peptide attenuates cellular and humoral responses against tAChR and suppresses clinical EAMG.
description
2002 nî lūn-bûn
@nan
2002 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Vaccination with a MHC class I ...... and suppresses clinical EAMG.
@ast
Vaccination with a MHC class I ...... and suppresses clinical EAMG.
@en
Vaccination with a MHC class I ...... and suppresses clinical EAMG.
@nl
type
label
Vaccination with a MHC class I ...... and suppresses clinical EAMG.
@ast
Vaccination with a MHC class I ...... and suppresses clinical EAMG.
@en
Vaccination with a MHC class I ...... and suppresses clinical EAMG.
@nl
prefLabel
Vaccination with a MHC class I ...... and suppresses clinical EAMG.
@ast
Vaccination with a MHC class I ...... and suppresses clinical EAMG.
@en
Vaccination with a MHC class I ...... and suppresses clinical EAMG.
@nl
P2093
P1433
P1476
Vaccination with a MHC class I ...... and suppresses clinical EAMG.
@en
P2093
M Zouhair Atassi
Minako Oshima
Philip Deitiker
Tetsuo Ashizawa
P304
P356
10.1080/08916930290022270
P577
2002-05-01T00:00:00Z